The document is an intimation regarding the availability of an audio recording for an earnings call.
The event type is an earnings call, specifically for the discussion of Q1 FY27 results.
The call was held on 31st July 2026, as indicated by the date of the disclosure and the timestamp on the digital signature.
The stated purpose of the event was to discuss quarterly results, as it is referred to as an "earnings call" for "Q1 FY27".
The meeting occurred after the earnings announcement, as it follows a prior intimation dated 14th July 2026.
The management participant mentioned is Anoop Deshpande, who is the Company Secretary and Compliance Officer, signing the disclosure.
A presentation or earnings deck is not mentioned as being available; only the audio recording is disclosed.
The audio recording of the call is available on the company's website at the provided link: https://sunpharma.com/wp-content/uploads/2026/07/FY27-Q1-Earnings-Call-Recording-10044975.mp3.
The disclosure is made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It does not explicitly state that no unpublished price sensitive information (UPSI) was shared.
Additional Notes Section
No financial highlights, guidance references, or presentation summaries are included in this specific disclosure text.
The document itself is a compliance filing and does not contain any attached financial data, earnings deck, or transcript.
This is a standalone announcement to inform about the availability of the call recording; no financial figures are disclosed herein.
